VYNE Therapeutics (VYNE) EPS (2017 - 2026)
VYNE Therapeutics (VYNE) EPS from Mar 31, 2017 to Mar 31, 2026. The TTM VYNE Therapeutics (VYNE) EPS is -$1.75. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
VYNE Therapeutics (VYNE) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -85.89% |
| 3 Years TTM | -66.25% |
| 5 Years TTM | -58.43% |
| All Time TTM | -49.23% |
Annual EPS change of VYNE Therapeutics (VYNE)
| Year | EPS | Change |
|---|---|---|
| 2026 | -$0.11 | -86.49% |
| 2025 | -$0.79 | -70.41% |
| 2024 | -$2.69 | +33.10% |
| 2023 | -$2.02 | -71.92% |
| 2022 | -$7.19 | -93.51% |
| 2021 | -$110.77 | +4.12% |
| 2020 | -$106.39 | -43.32% |
| 2019 | -$187.70 | +226.95% |
| 2018 | -$57.41 | -41.84% |
| 2017 | -$98.71 | +105.96% |
| 2016 | -$47.93 | N/A |
Comparison VYNE Therapeutics (VYNE) five years EPS CAGR with competitors
VYNE Therapeutics (VYNE) five years EPS CAGR is -49.07%.